The structural brain changes in Alzheimer’s disease involve a pronounced loss of grey matter (GM) and an exacerbated increase in CSF, particularly noticeable in the ventricles.21,22 T2D is a metabolic disorder characterized by decreased insulin production and/or increased insulin resistance that impacts glucose level regulation. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.